#1 Clinical Trials Search in Europe

Acquired antithrombin III deficiency – Basic Information

Go back

Acquired antithrombin III deficiency is a serious blood clotting condition that develops when the body loses or doesn’t produce enough of a crucial protein that prevents excessive clotting, putting patients at significant risk of dangerous blood clots that can threaten life and limb.

What Is Acquired Antithrombin III Deficiency?

Acquired antithrombin III deficiency is a condition where a person develops low levels of a protein called antithrombin (sometimes called antithrombin III) not because they were born with it, but because of another illness or medical situation. Unlike hereditary deficiency that is passed down through genes, acquired deficiency happens during a person’s life due to other health problems[3].

To understand why this matters, it helps to know what antithrombin does. Antithrombin is like a brake pedal for your blood clotting system. When you get injured, your blood needs to clot to stop bleeding. But once the job is done, something needs to stop the clotting from going too far. That’s where antithrombin comes in. It works by turning off the clotting enzymes that make blood stick together[2].

When you don’t have enough antithrombin in your system, clotting can continue unchecked. Imagine filling a bathtub with water and then walking away without anyone there to turn off the faucet. The tub will overflow. Similarly, without enough antithrombin to stop it, your blood can form clots when and where they shouldn’t[2].

This situation puts people at high risk for serious complications, particularly deep vein thrombosis (blood clots in deep veins, usually in the legs) and pulmonary embolism (when a clot travels to the lungs). Both of these conditions can be life-threatening if not treated promptly[2].

Causes of Acquired Antithrombin III Deficiency

Acquired antithrombin III deficiency develops primarily due to two main mechanisms: the body consuming too much antithrombin or not producing enough of it. This differs fundamentally from the inherited form, where a genetic mutation prevents the body from making normal antithrombin from birth[3].

The deficiency is observed in situations where the coagulation system becomes abnormally activated. When the blood clotting system goes into overdrive, it uses up antithrombin faster than the body can replace it. Several serious medical conditions trigger this excessive consumption[3].

One of the most common causes is disseminated intravascular coagulation (DIC), a life-threatening condition where blood clots form throughout the body’s small blood vessels. This widespread clotting rapidly depletes antithrombin stores. Other conditions that damage blood vessel walls, such as hemolytic-uremic syndrome, also lead to increased antithrombin use[3].

Sepsis, a severe infection that affects the whole body, is another major cause. When the body fights a widespread infection, the immune response can trigger excessive clotting, consuming antithrombin in the process[3].

The liver plays a central role because it produces antithrombin. When someone has liver disease, their liver cannot manufacture enough antithrombin to maintain normal levels. This means people with conditions like cirrhosis or severe hepatitis are at risk for developing acquired deficiency[3].

In nephrotic syndrome, a kidney disorder, the kidneys leak protein into the urine. Because antithrombin is a protein, it gets lost through the kidneys along with other important proteins. This creates a shortage even though the liver is making antithrombin normally[3].

Patients undergoing bone marrow transplantation can develop a complication called veno-occlusive disease (VOD), which causes acquired antithrombin deficiency. Additionally, certain medications have been associated with lower antithrombin levels. Surprisingly, even heparin, a medication used to prevent blood clots, and oral contraceptives can contribute to antithrombin deficiency in some cases[3].

⚠️ Important
Acquired antithrombin III deficiency is fundamentally different from the inherited form. While inherited deficiency results from a genetic mutation present from birth, acquired deficiency develops due to other medical conditions during a person’s lifetime. This distinction is crucial because the treatment approach and prognosis may differ significantly between the two types.

Risk Factors

Several groups of people face higher risks of developing acquired antithrombin III deficiency based on their medical conditions or treatments. Understanding these risk factors helps doctors identify and monitor patients who might develop this dangerous condition.

Patients with severe infections, particularly those with sepsis, face significant risk. When the body mounts an intense immune response to fight infection, it can trigger widespread inflammation and clotting activation that rapidly depletes antithrombin reserves[4].

People undergoing major surgery represent another high-risk group. Surgical procedures, especially extensive operations, activate the clotting system as part of the body’s natural healing response. In some patients, this activation becomes excessive, leading to antithrombin consumption[4].

Patients requiring cardiopulmonary bypass during heart surgery are particularly vulnerable. This procedure, which temporarily takes over the function of the heart and lungs during surgery, can significantly stress the coagulation system and reduce antithrombin levels[4].

Premature infants naturally have lower antithrombin levels than full-term babies and adults. Their livers are still developing and may not produce adequate amounts of this protein. When these vulnerable babies develop complications requiring intensive care, their antithrombin levels can drop even further[4].

Bone marrow transplant recipients face elevated risk, particularly if they develop veno-occlusive disease. This complication damages liver blood vessels, interfering with normal liver function and antithrombin production[3].

Patients with chronic liver disease of any cause are at ongoing risk because their damaged livers cannot manufacture sufficient antithrombin. Similarly, people with kidney disease causing nephrotic syndrome continuously lose antithrombin through their urine, creating a persistent deficiency[3].

Symptoms

The symptoms of acquired antithrombin III deficiency relate primarily to the blood clots that form when this protective protein is lacking. These symptoms can range from uncomfortable to life-threatening, depending on where clots develop and how large they become.

Deep vein thrombosis is one of the most common manifestations. When a clot forms in a deep vein, typically in the leg, patients may experience swelling, pain, warmth, and redness in the affected limb. The leg might feel heavy or tender to touch. Sometimes one leg appears noticeably larger than the other due to swelling[2].

A pulmonary embolism occurs when a blood clot travels to the lungs. This is a medical emergency. Patients may suddenly experience shortness of breath, chest pain that worsens with breathing, rapid heart rate, coughing (sometimes with bloody sputum), and feelings of anxiety or dizziness. Some people feel like they cannot get enough air no matter how hard they breathe[2].

Although less common, blood clots can form in unusual locations. Clots in veins of the abdomen can cause severe abdominal pain, nausea, vomiting, and bloating. Clots affecting brain veins may cause headaches, vision changes, seizures, or stroke-like symptoms[2].

It’s important to note that in acquired deficiency, patients often have symptoms from their underlying condition as well. Someone with sepsis will have fever, confusion, and signs of infection alongside the clotting problems. A person with liver disease might have yellowing of the skin, fluid accumulation in the abdomen, and easy bruising in addition to clot-related symptoms.

Prevention

Preventing acquired antithrombin III deficiency focuses on managing the underlying conditions that cause it and protecting high-risk patients during vulnerable periods. Because this condition develops as a consequence of other illnesses, prevention strategies target both the root causes and the risk situations.

Early and aggressive treatment of infections, particularly sepsis, helps prevent the severe activation of the clotting system that depletes antithrombin. Prompt antibiotic therapy, proper fluid management, and supportive care in intensive care settings can reduce the likelihood of developing severe acquired deficiency[4].

For patients undergoing major surgery or procedures like cardiopulmonary bypass, doctors may monitor antithrombin levels and consider preventive measures. While specific prevention protocols vary, careful surgical technique and minimizing unnecessary activation of the clotting system help preserve antithrombin stores[4].

Managing chronic conditions that cause acquired deficiency is crucial for long-term prevention. This includes optimal treatment of liver disease to support the liver’s ability to produce antithrombin, and careful management of nephrotic syndrome to reduce protein loss through the kidneys[3].

For patients known to have acquired antithrombin deficiency, preventing blood clots becomes a priority. This might involve staying mobile rather than remaining in bed for extended periods, wearing compression stockings, staying well-hydrated, and in some cases, using blood-thinning medications as prescribed by a doctor.

In certain high-risk situations, such as bone marrow transplantation, doctors monitor patients closely for signs of veno-occlusive disease and other complications that could lead to antithrombin deficiency. Early detection allows for prompt intervention before severe problems develop[3].

Pathophysiology

Understanding how acquired antithrombin III deficiency affects the body requires looking at the normal role of antithrombin and what happens when it’s depleted. The pathophysiology involves complex interactions between the clotting system, the inflammatory response, and various organ systems.

Normally, antithrombin serves as one of the body’s most important natural anticoagulants. It works by inhibiting several key enzymes in the clotting cascade, particularly thrombin (also called factor IIa) and factor Xa. These enzymes drive the formation of blood clots. By neutralizing them, antithrombin keeps clotting under control[4].

The liver produces antithrombin as a glycoprotein, a molecule made of protein with attached sugar groups. Under normal circumstances, the liver maintains steady production, keeping blood levels in a range that effectively regulates clotting. Normal antithrombin concentration in blood plasma ranges from 0.125 to 0.160 milligrams per milliliter, which translates to about 80 to 120 percent of standard activity[6].

Antithrombin’s effectiveness is dramatically enhanced by heparin, a natural substance found on blood vessel walls and also used as medication. When heparin binds to antithrombin, it causes a shape change in the antithrombin molecule that makes it much more powerful at stopping clotting enzymes. This is actually the main way heparin medications work to prevent blood clots[3].

In acquired deficiency, the balance breaks down through one of two mechanisms. In conditions like disseminated intravascular coagulation or sepsis, the clotting system becomes massively activated throughout the body. Small clots form in blood vessels everywhere, and this widespread clotting consumes antithrombin faster than the liver can replace it. It’s like trying to fill a bucket with a hole in the bottom—no matter how much you pour in, you can’t maintain the proper level[3].

In liver disease, the problem is production rather than consumption. The damaged liver simply cannot manufacture sufficient antithrombin. Similarly, in nephrotic syndrome, the kidneys inappropriately filter antithrombin into the urine, draining it from the bloodstream[3].

Research has revealed that antithrombin does more than just prevent clots. It also possesses anti-inflammatory properties. It can interact directly with cells lining blood vessels (endothelial cells) and influence inflammation. This dual role means that antithrombin deficiency may contribute to both clotting problems and inflammatory complications[4].

When antithrombin levels drop below critical thresholds, the body loses its ability to properly regulate clot formation. Clots may form spontaneously without injury, grow larger than necessary, or develop in locations where they shouldn’t. These inappropriate clots can block blood flow to vital organs, causing tissue damage or death. The severity of complications typically correlates with how low the antithrombin levels fall and how quickly the deficiency develops.

⚠️ Important
Antithrombin is critical for heparin medications to work properly. Patients with severe acquired antithrombin deficiency may not respond normally to heparin treatment for blood clots. Doctors need to carefully monitor these patients and may need to consider alternative anticoagulation strategies or antithrombin replacement therapy to ensure effective clot prevention and treatment.

Ongoing Clinical Trials on Acquired antithrombin III deficiency

References

https://www.stoptheclot.org/news/antithrombin-deficiency/

https://my.clevelandclinic.org/health/diseases/22251-antithrombin-deficiency

https://emedicine.medscape.com/article/954688-overview

https://pubmed.ncbi.nlm.nih.gov/17600391/

https://emedicine.medscape.com/article/954688-treatment

https://pmc.ncbi.nlm.nih.gov/articles/PMC10571690/

More information about
Acquired antithrombin III deficiency:

FAQ

What is the difference between acquired and hereditary antithrombin III deficiency?

Hereditary antithrombin deficiency is caused by a genetic mutation that you inherit from your parents and are born with. Acquired antithrombin deficiency develops during your lifetime due to other medical conditions such as liver disease, kidney problems, severe infections like sepsis, or disseminated intravascular coagulation. The acquired form results from either excessive consumption of antithrombin or decreased production by the liver, rather than a genetic defect.

Can acquired antithrombin III deficiency be reversed?

Yes, acquired antithrombin III deficiency can often be reversed or improved if the underlying cause is successfully treated. For example, if the deficiency is caused by sepsis and the infection is cured, antithrombin levels may return to normal. Similarly, if liver function improves or kidney disease is managed, antithrombin production and retention can be restored. However, in cases of permanent organ damage, the deficiency may persist.

Why might heparin not work well in someone with acquired antithrombin deficiency?

Heparin medications work by binding to antithrombin and making it much more effective at preventing blood clots. However, if someone has severe antithrombin deficiency, there isn’t enough antithrombin for the heparin to work with. This means the medication cannot achieve its full anticoagulant effect. In such cases, doctors may need to use alternative anticoagulation strategies or consider antithrombin replacement therapy.

What conditions most commonly cause acquired antithrombin III deficiency?

The most common causes include disseminated intravascular coagulation (DIC), sepsis, liver disease, nephrotic syndrome, and complications from bone marrow transplantation such as veno-occlusive disease. Major surgery and cardiopulmonary bypass procedures can also lead to acquired deficiency. Additionally, premature infancy is associated with naturally lower antithrombin levels that can become further depleted during illness.

How is acquired antithrombin III deficiency diagnosed?

The diagnosis is made through a specific blood test that measures antithrombin levels in the blood. Doctors typically order this test when someone has unexplained blood clots or when patients have conditions known to cause antithrombin deficiency. Normal antithrombin levels range from about 80% to 120% of standard activity. Additional tests may be performed to identify the underlying cause of the deficiency.

🎯 Key takeaways

  • • Acquired antithrombin III deficiency develops during a person’s lifetime due to medical conditions, unlike the inherited form which is present from birth due to genetic mutations.
  • • The condition puts people at high risk for dangerous blood clots including deep vein thrombosis and pulmonary embolism because antithrombin normally acts as a brake on the clotting system.
  • • Common causes include severe infections like sepsis, liver disease, kidney disease with protein loss, disseminated intravascular coagulation, and complications from bone marrow transplantation.
  • • The deficiency occurs through two main mechanisms: excessive consumption of antithrombin due to widespread clotting activation, or decreased production by a damaged liver.
  • • Antithrombin has dual roles—it prevents excessive blood clotting and also possesses anti-inflammatory properties that protect blood vessel walls.
  • • Heparin medications may not work effectively in patients with severe antithrombin deficiency because heparin requires adequate antithrombin to produce its anticoagulant effect.
  • • Unlike hereditary deficiency which is permanent, acquired deficiency can often be reversed if the underlying medical condition causing it is successfully treated.
  • • High-risk groups include patients undergoing major surgery, those on cardiopulmonary bypass, premature infants, and people with chronic liver or kidney disease.

Connected medications: